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Neurons communicate via chemical signals called neurotransmitters (NTs). The numerous identified NTs
can have very different physiochemical properties (solubility, charge, size etc.), so quantification of the
various NT classes traditionally requires several analytical platforms/methodologies. We here report that a
diverse range of NTs, e.g. peptides oxytocin and vasopressin, monoamines adrenaline and serotonin, and
amino acid GABA, can be simultaneously identified/measured in small samples, using an analytical
platform based on liquid chromatography and high-resolutionmass spectrometry (LC-MS). The automated
platform is cost-efficient as manual sample preparation steps and one-time-use equipment are kept to a
minimum. Zwitter-ionic HILIC stationary phases were used for both on-line solid phase extraction (SPE)
and liquid chromatography (capillary format, cLC). This approach enabled compounds from all NT classes
to elute in small volumes producing sharp and symmetric signals, and allowing precise quantifications of
small samples, demonstrated with whole blood (100 microliters per sample). An additional
robustness-enhancing feature is automatic filtration/filter back-flushing (AFFL), allowing hundreds of
samples to be analyzed without any parts needing replacement. The platform can be installed by simple
modification of a conventional LC-MS system.
N
Ts are metabolites used for communication between neurons in the brain. In humans, analysis of
cerebrospinal fluid (CSF) gives the most direct measure of central NT levels. Due to their less invasive
nature, neuroimaging approaches such as positron emission tomography (PET) andmagnetic resonance
(MR) spectroscopy1,2 are promising alternatives. However, the cost, availability and practicality aspects of CSF
extraction and neuroimaging have led many studies to rely on quantification of NTs from blood, saliva or other
peripheral fluids.
Measuring levels of various NTs (e.g. GABA, serotonin and its precursor tryptophan, adrenaline, oxytocin and
vasopressin) in blood or other bio-fluids gives valuable information for several purposes. Some studies point to
differences in peripheral NT levels as potential biomarkers for psychiatric conditions (e.g. serotonin3), or use
blood measures of NTs to validate experimental neuroscience methods4,5. Peripheral NT levels have also repeat-
edly been shown to correlate with e.g. parent-infant attachment, e.g. neuropeptides oxytocin and vasopressin6.
Central oxytocin (OT) levels are thought tomediate the link betweenOT levels in plasma and behaviour, although
the highly limited ability ofmanyNTs to cross the blood brain barrier render the relationship between central and
peripheral levels less clear7. Therefore, reliable, valid and sensitive analytical methodologies are required to
further establish the roles and predictive traits of peripheral NTs.
A further complication of employing peripheral NT levels is that reliability and validity can be questionable.
Different methods of quantification do not always give comparable results. For OT, McCullough et al8 recently
pointed to a discrepancy of up to 100-fold between conventional radioimmunoassay (RIA) and the newer,
commercially available enzyme immunoassay (EIA) approach. The authors suggest that such EIA measures
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may misattribute other molecules to OT. Moreover, RIA and EIA
methodologies are intended for specific compounds, and can be very
time-consuming to establish, reducing method flexibility for e.g.
identifying novel metabolite candidates for brain/blood level
correlations9.
Another obstacle is the difficulty with obtaining convincing data
from small amounts of sample. Recently, Clark et al10 analysed cere-
brospinal fluid (CSF) samples from human infants and showed a
correlation between neuropeptide levels and behaviour. The authors
were however unable to address the correspondence between plasma
and CSF peptide levels, since the amount of blood required for con-
ventional analysis of plasma OT exceeded the amount that could
safely be drawn from neonates.
An alternative to RIA and EIA is mass spectrometry (MS) based
methodology. MS provides detailed information of detected com-
pounds, including molar mass, charge, and (clues to) its molecular
structure (when employing tandem MS). MS is commonly coupled
with liquid chromatography (LC), which separates compounds in a
sample from each other, prior to MS detection. This step enhances
e.g. sensitivity, as fewer compounds enter the MS per time, reducing
ion suppression11. LC-MS is common instrumentation in modern
analytical laboratories, and is associated with excellent validity and
high accuracy/precision measurements, especially when internal
standards are used, e.g. adding known amounts of an isotopically
labelled version of each analyte (e.g. the NTs) to the sample, which
are used to correct for variances that can occur during sample pre-
paration/LC-MS recording.
However, reported LC-MS methods for NT determinations are
often intended for rather large amounts of sample12–14 and may
therefore not be suitable for analysis of limited, precious samples
from e.g. infants and blood banks. Also, they are typically not suited
for measuring all classes of NTs at once, due to the significant vari-
ation of physiochemical properties of NTs, such as hydrophobicity
and charge. Simultaneous determination of members from all NT
classes would be desirable as NTs can interact extensively, as is well
documented across human and non-human models. LC-MS meth-
odsmay however also require a number ofmanual preparation steps,
e.g. enriching the compounds with solid phase extraction (SPE) col-
umns prior to LC-MS, thereby increasing analysis cost.
Our goal was to develop an LC-MS platform that would be capable
of analysing samples to quantify all NT classes. Moreover, we wanted
the platform to have high sensitivity, allowing analysis of minute
samples. In addition, we wanted the platform to be automated, but
at the same time very robust. Our proposed solution is to employ LC-
MS, with LC performed in hydrophilic interaction mode (HILIC)15,
coupled with on-line solid phase extraction (SPE)16 and automated
filtration/filter backflushing (AFFL)17. The LC column was in capil-
lary format (cLC). The SPE step is also performed in HILIC mode,
and is compatible with protein precipitation using acetonitrile
(ACN) with 0.1% formic acid (FA), allowing direct analysis of the
supernatant with no additional steps. We will here describe the ver-
satility of the method and demonstrate its sensitivity, quantification,
reliability and other traits.
Results
The main results were: neurotransmitters/precursors with a wide
range of physiochemical properties (see structures and other data,
Fig. 1) could be identified/measured in a single analysis, needing only
100 mL of whole blood (see cLC-MS chromatograms of endogenous
NTs and isotopically labelled internal standards (IS), Fig. 2).
Identifications were based on retention time matching with stan-
dards and spectra obtained with high resolution MS. A novel, auto-
matedAFFL-SPE-cLC-MS analytical platformwas developed for this
purpose (Fig. 3 and Supplementary Fig. S1). The automated platform
could be used for reliable trace determinations, evaluated with NT
monoamines and amino acids with readily available labelled internal
standards; see calibration curves and validation tables (Fig. 4). Due to
the platform’s sensitivity and versatility, trace levels of the much
larger neuropeptides oxytocin and vasopressin could also be easily
detected (Fig. 2g and n). The platform provided good and similar
chromatographic quality for monoamines, amino acids and peptides
(Fig. 2), suggesting that AFFL-SPE-cLC-MS is a suitable platform for
comprehensive NT determinations in small samples. Below is amore
detailed presentation of the results and technical aspects.
Method development. Initially, two commercial zwitter-ionic HILIC
columns for cLC separations were examined, (a) ZIC-HILIC18 and
(b) ZIC-cHILIC19. Both have zwitter-ionic stationary phases, but
while (a) has a sulphobetaine type functionality (quaternary ammo-
nium part5 positive charge, sulphonic acid part5 negative charge),
where the negative charge is the most accessible to interacting solutes,
(b) has a phosphorylcholine type functionality (phosphate part 5
negative charge, quaternary ammonium part 5 positive charge),
where the positive charge is the most accessible. Neither of the two
15 cm long columns provided a baseline separation of all the NT
analytes. However, since the analytes have distinct retention times,
exact masses and/or MS/MS transitions (Table 1) and the platform
provides satisfactory quantitative performance (see below), baseline
separation was not considered to be a necessity. The efficiency (plate
number N, see Supplementary note Calculation of efficiency), and
asymmetry factor (As, see Supplementary Fig. S2, for details) of the
platform were somewhat better with (b) (see N values in caption of
Fig. 2), hence the ZIC-cHILIC column was employed. Best resolution
(Rs) and N were achieved with a mobile phase consisting of 70%
ACN and 30% 100 mM ammonium formate at pH 3 (see Supple-
mentary note Mobile phases, for brief discussion on other mobile
phases examined). In addition, 300 mM ascorbic acid (anti-oxidant)
was added to the mobile phase to avoid online-oxidation effects20,21
(see Supplementary note Online oxidation).
An AFFL set-up22 was used for on-line sample filtration (Fig. 3,
part A), using a stainless steel filter, and subsequent back-flushing of
the filter. This approach eliminated the need for single-use filters,
and manual handling of these, thereby allowing for hundreds of
whole blood sample injections without hardware replacement
(including filter, columns etc.). On-line SPE16 (Fig. 3, part B) was
employed to automatically enrich the NTs prior to cLC separation,
eliminating also the need for single-use SPE cartridges (and manual
handling of these). Best performance was obtained using a ZIC-
HILIC SPE column, compared to porous graphitic carbon- and ion
exchange SPEs (see Supplementary note SPE column materials, and
discussion below), with a 100% ACN loading solvent and a two
minute SPE loading time. A ZIC-cHILIC SPE column was not avail-
able to us during the study, and therefore not investigated. At least
100 mL of acetonitrilic sample volumes (resulting from the protein
precipitation step, see Methods section below) could be loaded on to
the SPE without an analyte breakthrough occurring (see Supple-
mentary Fig. S3). The cLC mobile phase successfully eluted the NT
analytes from the SPE to the cLC column, and the analytes were
chromatographed/detected in less than 9 minutes. Including the
two-minutes loading time and one-minute post-run SPE re-equilib-
ration time, the platform analysis time cycle was 12 minutes per
sample. The only sample preparation was a one-step ACN (with
0.1% FA) precipitation.
Method validation. Viewing Fig. 4 in more detail, the within-day
and between-day repeatabilities (n5 6 and n5 5, respectively) were
satisfactory for quantification, i.e.#20% relative standard deviation
(RSD), as according to Federal Drug Agency (FDA) validation
guidelines23, from lowest concentrations (between 0.05 nM and
250 nM, depending on the analytes expected endogenous levels)
and up to three orders of magnitude, with good linearity (r2 5
0.990 to 0.999) in both spiked blood and aqueous standard
samples using the Orbitrap MS. Of the analytes investigated,
www.nature.com/scientificreports
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serotonin had the lowest RSDs (within-day: 2–5%, between day: 3–
7%) while adrenaline had the highest RSDs (within-day: 5–13%,
between-day: 14–17%). In blood, the recoveries of the (spiked)
neurotransmitters varied from 33% for dopamine up to 91% for
serotonin, which were corrected for using isotope labelled internal
standards added prior to sample preparation, which was one-step
protein precipitation with ACN and 0.1% FA, see Methods section
below). Oxytocin and vasopressin (endogenously present at low pg/
mL levels8) were also easily detected at quantifiable levels (i.e. signal
to noise (S/N) . 20) with the same sample preparation. The
concentration limit of detection (cLOD) varied from 0.2 nM for
GABA and adrenaline, up to 30 nM for tryptophan (see Supple-
mentary note Calculation of cLOD). For all analytes, carry-over
was below the LOD (S/N , 3) for all concentrations tested, except
the ‘‘XH’’ level (see Supplementary Table S4 for details), which was
approximately 50 times higher of that expected of endogenous levels.
Hence, blank injections between samples were not necessary. The
same columns (SPE and analytical) were used for the entire study
(.1000 injections) without need for regeneration/cleaning.
The analyte stability in whole blood was demonstrated by re-ana-
lysing a number of compounds in samples after 1 week storage at 4uC
and 220uC, after 24 h, 48 h and 1 week at room temperature, and
after two freeze/thaw cycles. The analyte peak areas from the re-
analyses were compared to the initial peak areas from day 1. At
4uC,220uC, and after 2 freeze-thaw cycles, the stability was satisfact-
ory for all the neurotransmitters in the sample (i.e. no decrease in
peak areas). Serotonin and GABA were stable at room temperature
for 48 h, but not 1 week, while the dopamine peak area was some-
what reduced after only 24 h at room temperature. The other neu-
rotransmitters were stable at room temperature for at least 1 week. In
aqueous standards (diluted with ACN/H2O, 70/30), some degree of
instability was observed at room temperature and 4uC over night,
hence fresh working solutions were made daily, and the stock solu-
tions were stored at 280uC.
Discussion
Neurotransmitters/precursors could be identified/measured in a sin-
gle analysis, needing only 100 mL of whole blood, using a novel
automated AFFL-SPE-cLC-MS analytical platform.
Several LC-MS methods12–14,24–26 have been reported for polar NT
determination, but disadvantages can be the need for extensive man-
ual sample preparation and large sample amounts, etc. For the more
Figure 1 | Neurotransmitter molecular structures and info.Molecular structures of the six small neurotransmitters and the amino acid sequence of the
two neuropeptides. A table withmolar mass (Mm), octanol-water partition coefficient (log P) and pKa values of all analytes are included (values obtained
from SciFinder (CAS, Columbus, OH, USA)).
www.nature.com/scientificreports
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hydrophobic neuropeptides, standard reversed phase (RP) stationary
phases have traditionally been used27,28. Disadvantages of such
approaches are that they are limited to compounds of some hydro-
phobicity, and can therefore not be applied for small polar NT with-
out the use of ion-pairing reagents (typically not compatible with
MS) or chemical derivatization of the analytes (significantly adding
to time spent on sample preparation). To our knowledge, no previous
reports have demonstrated the ability to simultaneously handle both
very hydrophilic and hydrophobic NTs.
Hence, key advantages of the presented AFFL-SPE-cLC-MS plat-
form include simultaneous handling of polar NTs as well as neuro-
peptides with enhanced sensitivity (enabling analysis of small
samples), a high degree of automation and increased speed.
The sensitivity is much attributed to the high-end mass Q-
ExactiveTM Orbitrap spectrometer29 employed, but also to the use
of capillary columns; using cLC reduces radial dilution of the analytes
during chromatography compared to conventional columns16, and
employs lowered flow rates; both these features are associated with
elevated sensitivity in ESI-MS16,30. The sensitivity of the platform
allowed for analyte determinations with internal standards or iden-
tification of all compounds except for dopamine, which was present
below LOD (S/N# 3). This was somewhat expected due to its rapid
metabolism. Therefore, its lack of signal served de facto as a negative
control, but will likely be measured in other samples, as the cLOD
(determined with spiked samples) was relatively low (below 1 nM).
Conventional bore HILIC columns (e.g. 1–2.1 mm IDs) would also
be able to handle monoamines, amino acids and peptides simulta-
neously, but one should expect a decreased sensitivity compared to
using cLC. Although a ZIC-cHILIC column was chosen for this
platform, the more common ZIC-HILIC column should perform
nearly as well, but with some differences in selectivity31, i.e. the ability
to separate various compounds.
Simultaneous determination of both polar analytes as well as neu-
ropeptides would be far more challenging with the more common
Figure 2 | LC-MS chromatograms of neurotransmitters identified in whole blood sample. Chromatograms showing the endogenous NTs
identified/measured in awhole blood sample from ahealthy volunteer with nomedical history of importance. The endogenousNTpeak is comparedwith
the internal standard (IS) peak and the retention times are included. (a) GABA (plate numberN5 16 000), (b) GABA-IS, (c) PEA (N5 12 000), (d) PEA-
IS, (e) dopamine (no N calculated), (f) dopamine-IS, (g) oxytocin (N5 6000, no IS available), (h) serotonin (N5 6000), (i) serotonin-IS, (j) adrenaline
(N5 19 000), (k) adrenaline-IS, (l) tryptophan (N5 4000), (m) tryptophan-IS and (n) vasopressin (N5 10 000, no IS available). All chromatograms
were obtained from the same recording.
www.nature.com/scientificreports
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reversed phase LC approach, which separates according to hydro-
phobicity (typically limiting applicably to compounds with inter-
mediate/low polarity). In contrast, HILIC columns separate
compounds based on a number of factors, e.g. partitioning between
an immobilized water layer in the stationary phase and the mobile
phase, normal phase/adsorption interactions, electrostatic interac-
tions, hydrogen bonding but also reversed-phase (RP) interac-
tions18,32–34. The use of HILIC may also enhance sensitivity
compared to RP, as relatively high amounts of ACN are used in
the HILIC mobile phase, which can increase the MS signal35.
Conventional cLC injections are limited to 5–10 mL injections.
Here, we used on-line SPE to performmuch larger injection volumes
(100 mL) to lower the detection limits without compromising chro-
matography. On-line SPE also greatly reduces manual steps in sam-
ple preparation, which can be a central source of error in analysis36.
On the other hand, on-line SPE-LC can be prone to clogging when
handling complex samples22. To avoid this, the AFFL feature was
employed, ensuring robust performance. AFFL-SPE-cLC is straight-
forward to install17,22 and is compatible with common commercial
LC-MS instrumentation, only requiring one extra pump and one
switching valve. Whole blood samples are notorious for clogging
LC equipment. We largely attribute the absence of problems analys-
ing whole blood samples to the AFFL feature, which captures par-
ticulate matter with a filter that is back-flushed after each injection.
Using a zwitter-ionic HILIC phase also for SPE was superior to
using ion exchange (IEX) phases or porous graphitic carbon (PGC)
phases; IEX-HILIC and PGC-HILIC were associated with reduced
LC performance due to poor retention, or the ZIC-cHILIC separa-
tion column being incompatible with aqueous/very salty SPE loading
solvents. This does not appear to be a significant issue when employ-
ing larger bore SPE-LC systems37, but becomes a factor with small-
bore systems (such as cLC), where system void volumes can play a
larger role in system performance38. The ‘‘HILIC-HILIC’’ combina-
tion for SPE-LC has also been successfully used in proteomics and
glycoproteomics38,39. To the authors’ knowledge, this is the first
report on ‘‘HILIC-HILIC’’ SPE-LC for studying endogenous NTs/
metabolites.
To ensure full analyte retention on the HILIC SPE, the aqueous
standards were diluted with ACN/H2O (70/30). Based on this, ACN
with 0.1% FA was used to precipitate proteins from the whole blood
samples, in a 1 1 7.5 ratio (blood 1 precipitant). This allowed the
blood samples to be directly injected onto the AFFL-SPE system,
without any evaporation/re-dissolving step, making sample prepara-
tion both time-efficient and easy, with a minimum of manual work.
Since whole blood could be analysed without plasmafication, addi-
tional time andmanual work were saved, and the blood sample could
be analysed less than one hour after the blood was collected.
When performing targeted determination and quantifications,
triple quadrupole (3Q) instruments are often preferred, as they are
known for their excellent quantitative capabilities. Orbitrap instru-
ments are however superior29 in resolution, and more typically used
for untargeted analysis (e.g. comprehensive proteomics). This study
exemplifies that precise quantifications of small metabolites can be
successful with an Orbitrap instrument. In fact, linear calibration
curves were obtained even without correction with internal stan-
dards (Supplementary Fig. S4), which implies relatively trustworthy
quantifications for untargeted metabolomics as well. Considering
that miniaturized HILIC-Orbitrap-based LC-MS systems work
well for both proteomics38,39 and NTs (and likely other metabolites)
as described here, it is worth considering that a single instrument
set-up similar to that described here can be used for both bottom-
up proteomics and metabolomics, allowing their simultaneous
determination.
Few methods on quantitative determination of NTs in human
whole blood have been published, and reference materials are to
the authors’ knowledge, not available. However, the endogenous
levels quantified by our method were comparable (but somewhat
higher) to levels reported in plasma samples (Supplementary Table
S2). The reason is likely the high uptake of several neurotransmitters
in blood platelets40, and indeed the levels of some of the analytes were
lower in plasma, especially serotonin (measuredwith a non-validated
method).
We have demonstrated that AFFL-SPE-cLC-MS can be used for
quantifying NTs in small amounts of blood, with minimal sample
Figure 3 | Illustration of AFFL-SPE-cLC-MS system. The two switching positions of the AFFL-SPE system, (1) ‘‘load’’ and (2) ‘‘inject’’ are illustrated.
The shadowed areas A and B highlight the AFFL filter and the SPE, respectively.
www.nature.com/scientificreports
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preparation only including ACN precipitation. The platform can be
used for single-run chromatography of a wide range of NTs (mono-
amines, amino acids and peptides). Next steps will be to continue
adding analytes to the platform, towards more comprehensive ‘‘neu-
rotransmitter-omics’’, and validating the quantification of e.g. oxy-
tocin, whose labeled internal standard has become commercially
available at the time of submission (Sigma Aldrich, St. Louis, MO,
USA). Therapeutics affecting NT activity may also be monitored
simultaneously, as HILIC is compatible with drug analysis41.
Methods
For method development/validation/measurements, compound mixtures used were:
an external standard mixture consisting of commercially obtained compounds
($99% purity) (‘‘analyte standard mix’’, see Supplementary Table S3); a mixture of
Figure 4 | Validation data.Calibration curves for six NTs in spiked whole blood, including regression equations and R2 values (n5 2 for each level). The
non-zero values for b in ‘‘y5 ax1 b’’ are due to endogenous levels of the neurotransmitters in blood. The table to the right show validation data including
linear range, R2 values (in blood and standards), concentration limits of detection (cLOD), minimum detectable amounts (MDs) and recovery (%). The
table to the left shows the within-day and between-day repeatabilities of the NTs in spiked whole blood at the concentration levels L (low), M (medium)
and H (high). * No result for dopamine was obtained at the concentration level L, due to s/n , 10.
Table 1 | MS/MS transitions and retention times. The table presents theMS/MS transitions for all the NTs examined in this study, and for the
internal standards of the six small NTs. Isotope-labelled internal standards for the neuropeptides were not available at the time the study was
conducted. Retention times are also included
Analyte Internal standard
Neurotransmitter Precursor ion (m/z) Product ion (m/z) Precursor ion (m/z) Product ion (m/z) Retention time (min)
GABA 104.07 87.0443 106.09 89.0569 6.9
PEA 122.10 105.0699 127.13 110.1012 4.0
Dopamine 154.09 137.0593 158.11 141.0843 6.2
Serotonin 177.09 160.0751 181.13 164.1003 4.8
Adrenaline 184.10 166.0856 190.13 172.1233 6.7
Tryptophan 205.10 188.0699 208.12 191.0887 4.7
Oxytocin 1007.40 723.26 - - 5.4
Vasopressin 1084.45 * - - 8.4
*No considerable fragmentation for vasopressin was observed with fragmentation energy of 25 or 35%, so the precursor ion m/z (1084.455) was used for identification.
www.nature.com/scientificreports
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isotopically labelled analogs of the analytes, serving as internal standards (‘‘internal
standard mix’’, see Supplementary Table S3).
Study subjects and sample preparation.All subjects gave written informed consent,
and the blood collectionwas approved by the Regional Ethics Committee (2011/1337/
REK S-OE D). All methods were carried out in accordance with the approved
guidelines and regulations.
Whole blood samples from veins were collected in vials containing K2 EDTA (BD,
East Rutherford, NJ, USA), immediately aliquoted and stored at280uC until the time
of analysis. For validation studies, 8 blood samples were pooled prior to precipitation.
In 1.5 mL polypropylene vials (Eppendorf, Hamburg, Germany), aliquots of 100 mL
of thawed whole blood were mixed with 50 mL of an internal standard working
solution mixture (made by diluting the internal standard mixture 50 times, see
Supplementary Table S5 for details). Subsequently, 100 mL of ACN/H2O (70/30) was
added (to ensure equal volumes compared to that of spiked samples in validation
studies, see below) and finally 750 mL of cold ACN with 0.1% FA was rapidly added.
The vials were vigorously vortexed for 20 seconds before kept at 4uC for 20minutes, to
maximize the protein precipitation. Finally, the vials were centrifuged for 10 minutes
at 5000 rpm (Centrifuge 5415 R, Eppendorf). Approximately 700 mL of the super-
natant were collected, and 100 mL of this were injected directly onto the AFFL-SPE-
cLC-MS system.
AFFL-SPE-cLC-MS System. For all chemicals and equipment used, see
Supplementary Chemicals and equipment. An automated filtration/filter backflush
(AFFL)-SPE-cLC-MS system22 was used in this study (see Supplementary Fig. S1 for
an illustration of the entire system and Fig. 3 for details of the switching system). In
position 1 (load) the auto sampler injects 100 mL of sample, and then the sample is
pumped through a 1 mm stainless steel filter fitted in a union. The analytes will pass
through the filter and be retained on the SPE column, while un-retained non-polar
compounds and solvent will go directly to waste. The purpose of the filter is to prevent
larger particles from the sample e.g. precipitates, to reach and clog the SPE column. In
position 2 (inject) the 10 port valve is switched and the cLC pump elutes the analytes
off the SPE column and onto the analytical column. Simultaneously, the SPE pump
connected to the auto-sampler will back-flush the filter and wash off particles/
precipitates. For pump 1 the loading mobile phase was 100% ACN, the flow rate was
75 mL/min and the loading time 2 minutes. For pump 2 the LC mobile phase
consisted of 70% ACN and 30% 100 mM ammonium formate (pH 3, adjusted with
1% formic acid), and the flow rate was 4 mL/min. The column temperature was 30uC.
After being separated on the analytical column the analytes will be transferred to the
ESI where they are ionized before they enter the Orbitrap MS (See Supplementary
Table S1 for all MS parameters).
Method validation. Themethod was validated with samples made by spiking 100 mL
of pooled in-house whole blood with 100 mL of the analyte standard mix at seven
different concentration levels: XL, L, LM, M, HM, H and XH (Supplementary Table
S4). The rest of the procedure was the same as for the sample preparation (see section
above). The calibration samples weremade in the sameway as the validation samples,
and all samples were analysed on the same day as they were prepared. The within-day
repeatabilities were found by analysing 6 sample replicates of validation samples with
L, M and H concentration levels on the same day, while validation samples with L, M
and H concentrations were analysed on 5 different days to investigate the between-
day repeatabilities. The linearity was examined with standard solutions (n 5 3) and
with validation samples (n 5 7). The determination of the cLOD was limited by the
lack of blood without NTs (blank matrix). However, a crude estimate was calculated
by extrapolation (for details, see Supplementary note Calculations of cLOD).
The recovery was investigated in the following way: one pooled blood sample was
spikedwithNT analytes (XH level, tominimize contribution from endogenous levels)
before protein precipitation, and another pooled blood sample was spiked with NT
analytes after protein precipitation. To calculate the recovery, equation (1) was used.
A is the peak area of the analyte and Ais is the peak area of the internal standard,
respectively.
RECOVERY~100%|
A
Ais
A
Ais
pre{spike
post{spike
 !
ð1Þ
Stability was tested at room temperature, 4uC, 220uC and with thawing/freezing.
Validation samples from the first validation day were re-analysed after 24 h, 48 h, 1
week and after one and two thaw/freeze cycles, and peak areas were compared with
that of day 1.
Quantification of neurotransmitters in whole blood. To quantify the amounts of
NTs in the whole blood samples, calibration curves based on calibration samples with
concentrations from XL to XH (Supplementary Table S4), constructed using Excel,
were used. Since the calibration solutions were made by spiking blood which already
contained the neurotransmitters of interest, the endogenous levels of NTs were
calculated using the regression equation from the calibration curve, corrected for the
endogenous level (for details, see Supplementary note Calculation of NT
concentrations, and Supplementary Fig. S5).
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